Procurement Purchaser Agreement for COVID-19 Vaccine
Dear Financial Services and the Treasury Bureau Financial Services Branch,
On 17 August 2023, the Pretoria High Court ruled in the Health Justice Initiative's favor in the bid to compel the South African National Department of Health to provide access to all COVID-19 vaccine procurement contracts and other documents.
The Manufacturing and Supply Agreement between Pfizer and Laboratories Proprietary Limited and the Government of the Republic of South Africa Acting Through The National Department of Health of South Africa ("NDOH"), signed on 01 April 2023, has been released: https://healthjusticeinitiative.org.za/w...
In the Agreement, Under Purchaser Acknowledgement 5.5 Purchaser Acknowledgement, it states:
"Purchaser acknowledges that the Vaccine and materials related to the Vaccine, and their components and constituent materials are being rapidly developed due to the emergency circumstances of the COVID-19 pandemic and will continue to be studied after provision of the Vaccine to Purchaser under this Agreement. Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are not currently known. Further, to the extent applicable, Purchaser acknowledges that the Product shall not be serialized."
Please advise the context of the Purchaser Acknowledgement for the following COVID-19 vaccine in Hong Kong:
Product Name: COMIRNATY DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) 30 MICROGRAMS/DOSE
Registration No.: HK-67665
Product Name: COMIRNATY ORIGINAL/OMICRON BA.4-5 DISPERSION FOR INJECTION COVID-19 MRNA VACCINE (NUCLEOSIDE MODIFIED) (15/15 MICROGRAMS)/DOSE
Registration No.: HK-67666
Yours faithfully,
Rossi
This is to acknowledge receipt of your message. We shall reply to you,
where appropriate, as soon as possible. Thank you. (The above is generated
by an auto-reply programme.) Financial Services and the Treasury Bureau 我
們已收到你的電子郵件。如有需要，我們會盡快回覆。謝謝。 (以上為電腦自動發出
的訊息。) 財經事務及庫務局
Dear Financial Services and the Treasury Bureau Financial Services Branch,
Also, please advise the context of the Purchaser Acknowledgement for the following COVID-19 vaccine:
1. CoronaVac COVID-19 Vaccine (Vero Cell), Inactivated
2. Comirnaty COVID-19 mRNA Vaccine (BNT162b2) Concentrate for Dispersion
for Injection
3. Comirnaty 10 micrograms/dose Concentrate for Dispersion for Injection
COVID-19 mRNA Vaccine (nucleoside modified)
4. Comirnaty 3 micrograms/dose Concentrate for Dispersion for Injection
COVID-19 mRNA Vaccine (nucleoside modified)
5. Comirnaty Original/Omicron BA.4-5 (15/15 micrograms)/dose Dispersion
for Injection COVID-19 mRNA Vaccine (nucleoside modified)
Yours faithfully,
Rossi
This is to acknowledge receipt of your message. We shall reply to you,
where appropriate, as soon as possible. Thank you. (The above is generated
by an auto-reply programme.) Financial Services and the Treasury Bureau 我
們已收到你的電子郵件。如有需要，我們會盡快回覆。謝謝。 (以上為電腦自動發出
的訊息。) 財經事務及庫務局
Dear Financial Services and the Treasury Bureau Financial Services Branch,
May I follow up with you on the reply?
Yours faithfully,
Rossi
This is to acknowledge receipt of your message. We shall reply to you,
where appropriate, as soon as possible. Thank you. (The above is generated
by an auto-reply programme.) Financial Services and the Treasury Bureau 我
們已收到你的電子郵件。如有需要，我們會盡快回覆。謝謝。 (以上為電腦自動發出
的訊息。) 財經事務及庫務局
Dear Rossi,
Thank you for your email. Please be informed that your message has been
conveyed to the Department of Health and they will follow-up with your
enquiry. Thank you.
Financial Services Branch 財經事務科
Financial Services and the Treasury Bureau 財經事務及庫務局
The Government of the Hong Kong Special Administrative Region 香港特別行政
區政府
Email: [1][Financial Services and the Treasury Bureau Financial Services Branch request email]
Follow us on [2]Facebook | [3]Linkedin | [4]Instagram | [5]WeChat
[6]www.fstb.gov.hk
=============================
